- Advertisement -
Pfizer and its partner, BioNTech, announced the study on Tuesday.
COVID-19 vaccine makers have been updating their shots to better match omicron in case global health authorities decide the change is needed.
Vaccine maker Pfizer opens study of COVID jabs updated to match Omicron variant
- Advertisment -
